Analysed WINDTREE THERAPEUTICS INC (WINT:OTCMKTS) News Sources
Panacea Capital Leads Formation of Seismic Pharma to Advance Novel, Clinical-Stage Heart Failure Portfolio
30-03-2026
yahoo.com
Windtree Therapeutics Announces the Sale of its Cardiovascular Biotech Pipeline Drug Candidates
23-12-2025
yahoo.com
Windtree Therapeutics Announces It Has Signed a Letter of Intent to Acquire CommLoan, Inc. a Revenue Generating Company in the Rapidly Growing Fintech Space
03-12-2025
yahoo.com
Windtree Therapeutics Announces It May Receive License Agreement Payments from Its Licensee for Renewed Acute Pulmonary Development by the Licensee
17-11-2025
yahoo.com
Windtree Therapeutics Announces More Strengthening of Its Istaroxime and Next Generation SERCA2a activator Patent Estate
14-11-2025
yahoo.com
Windtree Therapeutics Announces It Will Receive $7.5 Million In Cash and Securities from the Recently Executed Termination Agreement with an Environmental Services Company
13-11-2025
yahoo.com
Nasdaq Boots Windtree a Month After $700M BNB Treasury Pivot Fails to Lift Stock
21-08-2025
decrypt.co
What is the current price of WINDTREE THERAPEUTICS INC (WINT:OTCMKTS)?
The current price of WINDTREE THERAPEUTICS INC (WINT:OTCMKTS) is $0.0169.
WINDTREE THERAPEUTICS INC (WINT:OTCMKTS) absolute price change since previous trading day?
The absolute price change of WINDTREE THERAPEUTICS INC (WINT:OTCMKTS) since the previous trading day is $0.0015.
WINDTREE THERAPEUTICS INC (WINT:OTCMKTS) percentage price change since previous trading day?
The percentage price change of WINDTREE THERAPEUTICS INC (WINT:OTCMKTS) since the previous trading day is 9.7403%.
What is the most recent average sentiment score for WINDTREE THERAPEUTICS INC (WINT:OTCMKTS)?
The most recent average sentiment score for WINDTREE THERAPEUTICS INC (WINT:OTCMKTS) is 62 out of 100.
What is the most recent average sentiment for WINDTREE THERAPEUTICS INC (WINT:OTCMKTS)?
The most recent sentiment for WINDTREE THERAPEUTICS INC (WINT:OTCMKTS) is .
SEC-8K** Filing Available For WINDTREE THERAPEUTICS INC (WINT:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.